sinc
fiv
discov
serolog
studi
demonstr
endem
domest
cat
popul
worldwid
seropreval
fiv
highli
variabl
region
estim
cat
clinic
sign
sick
cat
sick
adult
cat
male
cat
freeroam
cat
like
infect
major
rout
natur
transmiss
via
bite
vertic
transmiss
transmiss
cat
stabl
household
rel
uncommon
transmiss
mother
kitten
may
occur
offspr
becom
persist
infect
proport
depend
viral
load
queen
pregnanc
birth
queen
acut
infect
kitten
may
becom
infect
seroposit
queen
healthi
kitten
infect
although
neither
oronas
vener
spread
document
natur
cat
infect
experiment
viru
inocul
nose
mouth
vagina
rectum
viru
recov
semen
natur
experiment
infect
queen
may
infect
mate
bitten
infect
tom
cat
major
target
fiv
infect
activ
lymphocyt
cell
typic
function
helper
cell
central
role
immun
function
facilit
develop
humor
cellmedi
immun
fiv
envelop
glycoprotein
bind
primari
receptor
cell
surfac
molecul
viral
revers
transcriptas
mediat
transcript
rna
genom
dna
copi
proviru
errorpron
lack
proofread
function
thu
fiv
mutat
rapidli
display
great
genet
divers
viral
variant
may
evad
immun
detect
hamper
develop
molecular
diagnost
techniqu
vaccin
infect
becom
latent
cell
integr
proviru
copi
produc
viru
particl
unless
cell
becom
activ
latent
infect
cell
repres
reservoir
infect
reach
neutralis
antibodi
pose
obstacl
effect
vaccin
first
day
experiment
infect
fiv
replic
dendrit
cell
macrophag
lymphocyt
within
week
appear
plasma
viru
level
plasma
provir
dna
blood
mononuclear
cell
increas
reach
peak
week
infect
period
mild
moder
clinic
sign
anorexia
depress
fever
may
observ
condit
usual
subsid
rapidli
contrast
sign
generalis
lymphadenopathi
due
increas
number
size
activ
germin
centr
lymph
node
may
persist
week
month
decreas
plasma
viral
load
mark
begin
socal
asymptomat
phase
last
year
may
lifelong
assum
viral
replic
control
immun
respons
phase
infect
cat
remain
free
clinic
sign
final
outcom
follow
fiv
infect
variabl
asymptomat
phase
plasma
viru
load
stabl
progress
declin
lymphocyt
number
result
decreas
lymphocyt
ratio
proport
infect
cat
lead
function
immunodefici
clinic
sign
acquir
immunodefici
syndrom
aid
death
queen
acut
infect
kitten
may
becom
infect
seroposit
queen
healthi
kitten
infect
natur
infect
efficaci
colostr
immun
known
experiment
suscept
kitten
protect
passiv
transfer
antibodi
respons
challeng
laboratoryadapt
isol
fiv
howev
may
appli
challeng
virul
field
strain
inde
enhanc
infect
seen
transfer
antibodi
cat
immunis
experiment
vaccin
indic
fine
balanc
neutralis
infectionenhanc
antibodi
activ
immun
respons
cat
infect
fiv
remain
persist
infect
despit
mount
antibodi
cellmedi
immun
respons
felin
immunodefici
virusspecif
cytotox
cell
detect
blood
within
week
infect
coincid
peak
viraemia
antifiv
antibodi
includ
viru
neutralis
antibodi
appear
plasma
gener
appear
week
infect
seroconvers
may
delay
cat
expos
low
viru
dose
antibodi
recognis
env
appear
earlier
gag
protein
clinic
sign
directli
caus
fiv
vital
check
underli
caus
present
clinic
sign
mani
case
clinic
sign
result
secondari
infect
identifi
treat
see
later
viru
respons
immunodefici
make
cat
suscept
secondari
infect
neoplasia
immun
stimul
result
immunemedi
diseas
rare
case
fiv
caus
neurolog
diseas
first
week
month
infect
clinic
sign
last
day
week
may
seen
may
includ
mild
fever
lethargi
peripher
lymphadenopathi
haematolog
may
reveal
neutropenia
infect
cat
gener
remain
healthi
problem
associ
immunodefici
develop
asymptomat
period
last
year
case
cat
never
develop
fivrel
clinic
sign
diseas
often
seen
later
lifegener
year
age
older
immunodefici
andor
immunostimul
frequent
appear
form
chronic
gingivostomat
chronic
rhiniti
lymph
adenopathi
immunemedi
glomerulo
nephriti
weight
loss
fig
mani
concurr
viral
bacteri
fungal
protozo
infect
report
fivinfect
cat
unusu
sever
parasit
skin
diseas
eg
demodicosi
pediculosi
tumour
alert
clinician
possibl
fiv
infect
variou
neoplast
condit
b
cell
lymphosarcoma
myeloprolif
diseas
squamou
cell
carcinoma
report
associ
fiv
infect
chronic
gingivostomat
one
common
present
sign
fivinfect
cat
impair
cat
qualiti
life
fig
confirm
experiment
infect
neurovirul
strain
central
nervou
system
involv
peripher
neuropathi
earli
subclin
event
often
associ
alter
forebrain
peripher
nerv
electr
activ
contrast
immunochromatographi
test
detect
antibodi
recognis
short
peptid
transmembran
protein
western
blot
purifi
fiv
first
separ
gel
electrophoresi
constitu
protein
individu
fiv
protein
detect
antibodi
elisa
immunochromatographi
test
gener
appropri
limit
see
box
page
lymphocyt
possibl
stage
level
immun
dysfunct
determin
lymphocyt
count
howev
due
complex
assay
fact
clinic
situat
preinfect
valu
avail
test
clinic
use
disrupt
sleep
pattern
impair
learn
paresi
also
report
reproduct
failur
occur
infect
cat
associ
pcrposit
placent
fetal
tissu
renal
involv
aris
glomerular
tubulointerstiti
lesion
associ
sever
proteinuria
frequent
fivinfect
cat
renal
damag
caus
possibl
viru
togeth
renal
immun
deposit
polyclon
b
cell
activ
sustain
hyperglobulinaemia
high
level
circul
immun
complex
autoantibodi
asymptomat
period
last
year
case
cat
never
develop
fivrel
clinic
sign
well
strain
variat
lead
discrep
result
see
text
discrep
may
aris
serolog
pcr
compar
seropositivepcr
neg
result
may
explain
presenc
fiv
subtyp
recognis
pcr
rather
absenc
fiv
infect
aspect
import
cat
vaccin
fiv
abroad
seronegativepcr
posit
result
may
also
found
cat
live
close
contact
fivinfect
seroposit
cat
becom
proviru
posit
without
develop
antibodi
diseas
cat
infect
usual
seroconvert
week
month
later
fivinfect
cat
sick
prompt
accur
diagnosi
import
allow
earli
intervent
mani
respond
well
appropri
medic
although
longer
aggress
cours
therapi
eg
antibiot
may
need
uninfect
cat
clinician
report
benefit
corticosteroid
immunosuppress
drug
fivinfect
cat
chronic
stomat
use
controversi
side
effect
griseo
fulvin
caus
bone
marrow
suppress
use
filgastrim
granulocyt
colonystimul
factor
recombin
human
cytokin
rhugcsf
use
cat
profound
neutropenia
increas
neutrophil
count
may
also
lead
increas
viru
load
ebm
grade
iii
erythropoietin
avail
recombin
human
product
use
effect
cat
nonregen
anaemia
due
endogen
erythropoietin
defici
chronic
renal
failur
cat
fiv
treat
human
erythropoietin
iukg
sc
show
gradual
increas
red
white
blood
cell
count
ebm
grade
iv
increas
viru
load
observ
indic
human
erythropoietin
use
safe
insulinlik
growth
market
recombin
human
product
induc
thymic
growth
stimul
cell
function
treatment
result
signific
increas
thymu
size
thymic
cortic
regener
replenish
peripher
cell
pool
experiment
fivinfect
cat
ebm
grade
iii
could
consid
young
fivinfect
cat
studi
demonstr
efficaci
field
case
antivir
drug
discuss
licens
treat
hiv
infect
human
unfortun
mani
antivir
use
human
toxic
cat
ineffect
azt
azt
nucleosid
analogu
thymidin
deriv
block
retrovir
revers
transcriptas
azt
inhibit
fiv
replic
vitro
vivo
reduc
plasma
viru
load
enhanc
cat
immunolog
clinic
statu
improv
qualiti
life
placebocontrol
trial
azt
improv
stomat
natur
infect
cat
ebm
grade
appropri
dosag
mgkg
po
sc
higher
dose
use
care
side
effect
develop
sc
inject
jfm
clinic
practic
lyophilis
product
dilut
isoton
sodium
chlorid
solut
prevent
local
irrit
po
applic
syrup
gelatin
capsul
dosageweight
calcul
individu
cat
given
treatment
complet
blood
count
perform
weekli
first
month
nonregen
anaemia
common
especi
higher
dose
valu
stabl
monthli
check
suffici
cat
bone
marrow
suppress
treat
studi
fivinfect
cat
treat
year
show
azt
well
toler
cat
may
develop
mild
decreas
haematocrit
first
week
resolv
even
treatment
continu
haematocrit
drop
treatment
discontinu
anaemia
usual
resolv
within
day
hiv
aztresist
mutant
fiv
aris
earli
month
start
treatment
belong
new
class
bicyclam
act
select
antagonist
chemokin
receptor
molecul
main
coreceptor
cell
lineadapt
hiv
strain
block
viru
entri
inhibit
felin
immunodefici
viru
also
use
viru
entri
licens
antivir
compound
effect
fiv
vitro
placebocontrol
doubleblind
studi
natur
fivinfect
cat
treat
mgkg
sc
week
drug
caus
statist
signific
improv
clinic
sign
decreas
provir
load
side
effect
note
ebm
grade
interferon
felin
interferonomega
recent
licens
veterinari
use
european
countri
japan
interferon
antivir
immunomodulatori
antitumour
cyto
kine
speciesspecif
felin
interferonomega
therefor
use
durat
cat
life
without
induc
antibodi
also
contrast
experi
human
subject
side
effect
report
cat
cytokin
activ
fiv
vitro
control
studi
perform
field
cat
significantli
improv
surviv
rate
evid
ebm
grade
human
interferonalpha
induc
antivir
state
cell
also
immunomodulatori
effect
two
treatment
regimen
publish
treatment
retrovir
infect
cat
ebm
grade
iii
wherea
felin
interferonomega
avail
commerci
would
appropri
cytokin
use
rather
human
interferonalpha
abcd
recommend
cat
never
euthanas
sole
basi
fivposit
test
result
fivinfect
cat
may
live
long
uninfect
cat
ebm
grade
iii
howev
higher
risk
develop
clinic
sign
princip
due
secondari
infect
immunemedi
diseas
neoplasia
durat
asymptomat
stage
vari
accord
infect
variant
immun
modul
interferon
induc
wide
use
medic
fivinfect
cat
conclus
evid
control
studi
benefici
effect
health
surviv
rather
nonspecif
immun
stimul
lead
increas
viral
load
via
activ
latent
infect
cell
henc
diseas
progress
product
use
fivinfect
cat
risk
fiv
transmiss
low
household
social
welladapt
cat
one
cat
diagnos
fiv
infect
cat
household
test
viru
transmit
mainli
bite
fight
aggress
occur
due
stabil
social
territori
structur
probabl
transmiss
low
followup
studi
addit
cat
seroconvert
mani
year
cat
neuter
new
cat
introduc
might
disrupt
harmoni
even
cat
live
peac
togeth
long
time
infecti
diseas
spread
multicat
commun
risk
fiv
transmiss
may
also
higher
situat
isol
seroposit
cat
consid
felin
immunodefici
viru
import
consider
rescu
shelter
preval
infect
particularli
high
popul
feral
background
male
cat
preval
may
lower
preown
cat
recent
relinquish
compar
shelter
stray
cat
abcd
recommend
cat
test
achiev
least
sick
cat
test
euthanasia
consid
clinic
problem
relat
advanc
stage
fiv
infect
serolog
test
reliabl
identifi
infect
kitten
month
age
posit
result
confirm
kitten
infect
must
emphasis
indic
euthanasia
situat
diagnosi
pcr
may
consid
abcd
recommend
rescu
shelter
seroposit
cat
hous
individu
unless
household
absolut
minimum
fivposit
cat
segreg
fivneg
cat
shelter
home
fivposit
healthi
cat
select
adopt
offer
live
environ
risk
infect
cat
minim
detail
counsel
requir
usual
cat
breed
catteri
kept
indoor
test
annual
henc
fiv
rare
new
cat
test
introduc
breeder
use
extern
stud
allow
extern
queen
visit
stud
request
proof
fivneg
statu
cat
escap
return
quarantin
month
test
return
group
found
seroneg
european
advisori
board
cat
diseas
abcd
indebt
dr
karin
de
lang
judici
assist
organis
special
issu
effort
coordin
friendli
deadlinekeep
tireless
editori
assist
christina
espertsanchez
grate
acknowledg
groundwork
seri
guidelin
would
possibl
without
financi
support
merial
abcd
particularli
appreci
support
dr
jeanchristoph
thibault
respect
team
insist
scientif
independ
fiv
vaccin
commerci
avail
europ
experiment
protect
achiev
use
sever
immunogen
includ
inactiv
viru
infect
cell
canarypoxbas
antigen
express
combin
inactiv
cell
nake
dna
success
far
whole
inactiv
viru
prepar
one
vaccin
market
usa
sinc
australia
new
zealand
sinc
howev
vaccin
efficaci
test
challeng
european
field
isol
protect
cat
virul
uk
primari
fiv
isol
ebm
grade
iii
import
vaccin
cat
might
therefor
protect
natur
occur
european
isol
fiv
abcd
recommend
use
fiv
vaccin
europ
invalid
serolog
diagnosi
infect
may
protect
european
isol
surgeri
well
toler
asymptomat
fivinfect
cat
periop
antibiot
treatment
use
case
needl
surgic
instrument
use
fivposit
cat
may
transmit
viru
cat
strict
hygien
essenti
